Global Wound Care Biologics Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2023 –2029 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
>Globaler Markt für Biologika zur Wundversorgung, nach Produkt (biologische Hautersatzstoffe, topische Wirkstoffe), Wundtyp (Geschwüre, chirurgische und traumatische Wunden, Verbrennungen), Endverbraucher (Krankenhäuser, ASCs, Verbrennungszentren und Wundkliniken) – Branchentrends und Prognose bis 2029
Marktanalyse und Größe
Diabetes hat sich in allen Industrie- und Agrarländern zu einem weit verbreiteten Problem entwickelt. Diabetes tritt von Jahr zu Jahr häufiger auf und ebnet den Weg für wichtige Akteure auf dem Behandlungsmarkt. Der Markt für Wundpflege-Biologika ist einer der Gewinner. Die wachsende Zahl von Diabetikern gilt als wichtiger Faktor für das Wachstum des globalen Marktes für Wundpflege-Biologika. Zahlreiche Diabetiker leiden an diabetischen Geschwüren, die kleinere Operationen und Behandlungen erforderlich machen. Nach einem medizinischen Eingriff wird die Wunde des Patienten normalerweise mit einem Verband abgedeckt, der Medikamente zur Heilung enthält. Wundpflege-Biologika bieten solche Produkte, die zur Verbesserung der Behandlungsproduktivität beitragen.
Data Bridge Market Research analysiert, dass der Markt für Wundpflegebiologika bis zum Jahr 2029 voraussichtlich einen Wert von 3,11 Milliarden USD erreichen wird, was einer durchschnittlichen jährlichen Wachstumsrate von 3,80 % während des Prognosezeitraums entspricht. Der Anstieg der Zahl der Verbrennungen treibt das Wachstum des Marktes für Wundpflegebiologika voran.
Marktdefinition
Die Wundheilung ist ein komplexer Prozess, der die Synchronisierung und Aktivierung zahlreicher intra-, extra- und interzellulärer Elemente umfasst, wie etwa Kollagenkoagulation und -ablagerung, Epithelisierung, Bindegewebeansammlung, Wundkontraktion, Entzündungen, Gewebegranulation und Umbau. Wundpflege-Biologika sind biologisch hergestellte Produkte zur Behandlung nicht heilender Wunden an den unteren Extremitäten.
Berichtsumfang und Marktsegmentierung
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2022 bis 2029 |
|
Basisjahr |
2021 |
|
Historische Jahre |
2020 (Anpassbar auf 2019 – 2014) |
|
Quantitative Einheiten |
Umsatz in Mio. USD, Mengen in Einheiten, Preise in USD |
|
Abgedeckte Segmente |
Nach Produkt (biologischer Hautersatz, topische Wirkstoffe), Wundtyp (Geschwüre, chirurgische und traumatische Wunden, Verbrennungen), Endverbraucher (Krankenhäuser, ASCs, Verbrennungszentren und Wundkliniken) |
|
Abgedeckte Länder |
USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa, China, Japan, Indien, Südkorea, Singapur, Malaysia, Australien, Thailand, Indonesien, Philippinen, Restlicher Asien-Pazifik-Raum (APAC) im Asien-Pazifik-Raum (APAC), Saudi-Arabien, Vereinigte Arabische Emirate, Südafrika, Ägypten, Israel, Restlicher Naher Osten und Afrika (MEA) als Teil des Nahen Ostens und Afrikas (MEA), Brasilien, Argentinien und Restliches Südamerika als Teil von Südamerika. |
|
Abgedeckte Marktteilnehmer |
Smith & Nephew (Großbritannien), Mölnlycke Health Care AB (Schweden), Integra LifeSciences Corporation (USA), Wright Medical (USA), MiMedx Group (USA), Vericel Corporation (USA), Anika Therapeutics (USA), Osiris Therapeutics (USA), Organogenesis (USA), Kerecis (Island), Solsys Medical (USA), ACell (USA), Lavior Inc. (USA). Marine Polymer Technologies, Inc. (USA), Smith & Nephew (Großbritannien), Mölnlycke Health Care AB (Schweden) |
|
Gelegenheiten |
|
|
|
Marktdynamik für Biologika zur Wundversorgung
Treiber
- Die erhöhte Diabetes-Inzidenz
Einer der Hauptfaktoren, die das Wachstum des Marktes für Wundpflegebiologika vorantreiben, ist die Zunahme von Wundpflege- und -managementprogrammen. Der Anstieg der Diabetesfälle aufgrund von Fettleibigkeit, schlechter Ernährung und körperlicher Inaktivität sowie der Anstieg chronischer Wunden, insbesondere Fußgeschwüre, unter der diabetischen Bevölkerung treiben das Marktwachstum an.
Entwicklung besserer Behandlungsmöglichkeiten
Der Markt wird auch durch die Betonung der Entwicklung besserer Behandlungsmöglichkeiten sowie der enormen Krankheitslast und des Einsatzes von Technologien zur Behandlung von Entzündungen, Gewebeansammlungen, Kollagenablagerungen und der Bildung von Epithelzellschichten beeinflusst.
- Staatliche Investitionen für die Interoperabilität im Gesundheitswesen
Die Erhöhung der Mittel durch die Bundesregierung zur Förderung der Einführung dieser Lösungen beeinflusst den Markt zusätzlich. Darüber hinaus wirken sich der Anstieg der Gesundheitsausgaben, Fortschritte in der Gesundheitsinfrastruktur und die hohe Nachfrage nach erweiterter Gesundheitsversorgung positiv auf den Markt für Wundpflegebiologien aus.
Gelegenheiten
Verbesserungen der Gesundheitsinfrastruktur, erhöhte Investitionen im Biotechnologiesektor und eine Erhöhung der Gesundheitsausgaben wirken sich allesamt positiv auf Gewinnchancen aus.
Einschränkungen/Herausforderungen
Die hohen Kosten der Wundbehandlung und der Wundpflegebiologika sind ein Faktor, der das Marktwachstum voraussichtlich bremsen wird. Während des Prognosezeitraums wird das Risiko eines Hautersatzversagens voraussichtlich eine Herausforderung für den Markt für Wundpflegebiologika darstellen.
Dieser Marktbericht zu Wundpflegebiologika enthält Einzelheiten zu neuen Entwicklungen, Handelsvorschriften, Import-Export-Analysen, Produktionsanalysen, Wertschöpfungskettenoptimierungen, Marktanteilen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neue Einnahmequellen, Änderungen der Marktvorschriften, strategische Marktwachstumsanalysen, Marktgröße, Kategoriemarktwachstum, Anwendungsnischen und -dominanz, Produktzulassungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um weitere Informationen zum Markt für Wundpflegebiologika zu erhalten, wenden Sie sich an Data Bridge Market Research, um ein Analyst Briefing zu erhalten. Unser Team hilft Ihnen dabei, eine fundierte Marktentscheidung zu treffen, um Marktwachstum zu erzielen.
Auswirkungen von COVID-19 auf den Markt für Biologika zur Wundversorgung
Pharma- und Biotech-Unternehmen arbeiten in Zusammenarbeit mit Regierungen auf der ganzen Welt an der Bekämpfung des COVID-19-Ausbruchs, von der Impfstoffentwicklung bis hin zur Planung von Herausforderungen in der Arzneimittelversorgungskette. Derzeit befinden sich etwa 115 Impfstoffkandidaten und 155 Moleküle in der F&E-Pipeline. Darüber hinaus ist die Nachfrage nach häufig verwendeten Medikamenten wie Hydroxychloroquin zur Behandlung von COVID-19 dramatisch gestiegen. Da diese Medikamente in vielen Industrieländern knapp sind, hat die hohe Nachfrage enorme Chancen für Hersteller von COVID-19-Medikamenten geschaffen. Aufgrund der Nachfrage nach COVID-19-Impfstoffen und -Behandlungsmedikamenten wird erwartet, dass die Pharma- und Biotechnologiebranche in Zukunft erheblich wachsen wird.
Globaler Marktumfang für Biologika zur Wundversorgung
Der Markt für Biologika zur Wundbehandlung ist nach Produkt, Wundtyp und Endverbraucher segmentiert. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, die ihnen bei der strategischen Entscheidungsfindung zur Identifizierung der wichtigsten Marktanwendungen helfen.
Produkt
- Biologischer Hautersatz
- Topische Mittel
Auf der Grundlage des Produkts ist der Markt für biologische Wundpflegemittel in biologische Hautersatzstoffe und topische Mittel unterteilt. Biologische Hautersatzstoffe sind weiter unterteilt in Produkte aus menschlichem Spendergewebe, azelluläre Produkte tierischen Ursprungs und biosynthetische Produkte.
Wundtyp
- Geschwüre
- Chirurgische und traumatische Wunden
- Verbrennungen
Auf der Grundlage des Wundtyps ist der Markt für biologische Wundpflegeprodukte in Geschwüre, chirurgische und traumatische Wunden sowie Verbrennungen unterteilt. Venengeschwüre werden weiter unterteilt in Geschwüre, diabetische Fußgeschwüre, Dekubitusgeschwüre und andere Geschwüre.
Endbenutzer
- Krankenhäuser
- ASCs
- Verbrennungszentren
- Wundsprechstunden
- Sonstiges
Auf der Grundlage des Endverbrauchers ist der Markt für Biologika zur Wundversorgung in Krankenhäuser, Wundzentren, Verbrennungszentren und Wundkliniken segmentiert.
Regionale Analyse/Einblicke zum Markt für Wundpflegebiologika
Der Markt für Biologika zur Wundversorgung wird analysiert und es werden Einblicke in die Marktgröße und Trends nach Land, Produkt, Wundtyp und Endverbraucher bereitgestellt (siehe oben).
Die im Marktbericht für Biologika zur Wundpflege abgedeckten Länder sind die USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa, China, Japan, Indien, Südkorea, Singapur, Malaysia, Australien, Thailand, Indonesien, Philippinen, Restlicher asiatisch-pazifischer Raum (APAC) in Asien-Pazifik (APAC), Saudi-Arabien, Vereinigte Arabische Emirate, Südafrika, Ägypten, Israel, Restlicher Naher Osten und Afrika (MEA) als Teil von Naher Osten und Afrika (MEA), Brasilien, Argentinien und Restliches Südamerika als Teil von Südamerika.
Nordamerika dominiert das Produkt und den Wundtyp aufgrund der zunehmenden Verbreitung diabetischer Fußgeschwüre und der erhöhten Anfälligkeit für mikrobielle und pilzliche Hautinfektionen. Der asiatisch-pazifische Raum dürfte im Prognosezeitraum 2021–2028 aufgrund der Präsenz von Schwellenländern wie China, Japan und Indien sowie der Entwicklung der Gesundheitsinfrastruktur wachsen.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalysen, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.
Wachstum der Gesundheitsinfrastruktur, installierte Basis und Durchdringung mit neuen Technologien
Der Markt für Wundpflegebiologika bietet Ihnen außerdem detaillierte Marktanalysen für jedes Land, das Wachstum der Gesundheitsausgaben für Investitionsgüter, die installierte Basis verschiedener Arten von Produkten für den Markt für Wundpflegebiologika, die Auswirkungen der Technologie anhand von Lebenslinienkurven und Änderungen der regulatorischen Szenarien im Gesundheitswesen und deren Auswirkungen auf den Markt für Wundpflegebiologika. Die Daten sind für den historischen Zeitraum 2010–2020 verfügbar.
Wettbewerbsumfeld und Analyse der Marktanteile von Biologika zur Wundversorgung
Die Wettbewerbslandschaft auf dem Markt für Wundpflege-Biologika liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang, Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den Markt für Wundpflege-Biologika.
Einige der wichtigsten Akteure auf dem Markt für Wundpflegebiologie sind
- Smith & Nephew (Großbritannien)
- Mölnlycke Health Care AB (Schweden)
- Integra LifeSciences Corporation (USA)
- Wright Medical (USA)
- MiMedx Group (USA)
- Vericel Corporation (USA)
- Anika Therapeutics (USA)
- Osiris Therapeutics (USA)
- Organogenese (USA)
- Kerecis (Island)
- Solsys Medical (USA)
- ACell (USA)
- Lavior Inc. (USA)
- Marine Polymer Technologies, Inc. (USA)
- Smith & Nephew (Großbritannien)
- Mölnlycke Health Care AB (Schweden)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
TABLE OF CONTENTS GLOBAL WOUND CARE BIOLOGICS MARKET
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL WOUND CARE BIOLOGICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.2 DBMR MARKET CHALLENGE MATRIX
2.3 SECONDARY SOURCES
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING CASES OF DIABETIC FOOT ULCERS
3.1.2 INCREASING INCIDENCES OF BURN CASES
3.1.3 RISING NUMBER OF GERIATRIC POPULATION
3.1.4 INNOVATION IN WOUND CARE BIOLOGICS
3.1.5 NEW PRODUCT LAUNCHES
3.2 RESTRAINS
3.2.1 HIGH COST OF WOUND TREATMENT AND WOUND CARE BIOLOGICS
3.2.2 RISK OF SKIN SUBSTITUE FAILURE
3.3 OPPORTUNITIES
3.3.1 3D SKIN PRINTING
3.3.2 AWARENESS PROGRAMS
3.4 CHALLENGES
3.4.1 LACK OF WOUND MANAGEMENT SERVICES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SYNTHETIC SKIN GRAFTS
6.3 GROWTH FACTORS
6.3.1 PLATELET DERIVED GROWTH FACTOR (PDGF)
6.3.2 PLATELET RICH PLASMA (PRP)
6.3.3 EPIDERMAL GROWTH FACTORS (EGF)
6.3.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
6.3.5 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
6.3.6 TALACTOFERRIN ALFA
6.3.7 THROMBIN PEPTIDE
6.3.8 KERATINOCY GROWTH FACTOR (KGF)
6.4 ALLOGRAFTS
6.5 XENOGRAFTS
7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE
7.1 OVERVIEW
7.2 WOUNDS
7.2.1 SURGICAL WOUND
7.2.1.1 SKIN SURGERY
7.2.1.1.1 WOUND CLOSURE
7.2.1.1.2 SKIN BIOPSY
7.2.1.1.3 SKIN FLAP
7.2.1.1.4 SKIN GRAFT
7.2.1.1.5 OTHERS
7.2.1.2 COSMETIC PROCEDURE
7.2.1.2.1 BREST ENHANCEMENT
7.2.1.2.2 FACIAL CONTOURING
7.2.1.2.3 FACIAL REJUVENATION:
7.2.1.2.4 BODY CONTOURING
7.2.1.2.5 SKIN REJUVENATION
7.2.1.2.6 OTHERS
7.2.1.3 GYNECOLOGIC PROCEDURES
7.2.1.3.1 PUBOVAGINALIS SLING
7.2.1.3.2 PELVIC FLOOR RECONSTRUCTION
7.2.1.3.3 RECTOCELE REPAIR SURGERY
7.2.1.3.4 OTHERS
7.2.1.4 GASTROINTESTINAL PROCEDURE
7.2.1.4.1 GENERAL GASTROINTESTINAL SURGERY
7.2.1.4.2 HERNIA
7.2.1.4.3 OTHERS
7.2.2 ACUTE WOUNDS
7.2.3 CHRONIC WOUNDS
7.2.4 TRAUMATIC WOUNDS
7.3 BURNS
7.3.1 ULCERS
7.3.2 DIABETIC ULCERS
7.3.3 PRESSURE ULCER
7.3.4 VENOUS ULCER
7.3.5 OTHERS
8 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 WOUND CARE CENTERS
8.4 AMBULATORY SURGICAL CENTERS
8.5 CLINICS
8.6 COMMUNITY HEALTHCARE CENTER
9 GLOBAL WOUND CARE BIOLOGICS MARKET: GEOGRAPHY
9.1 GLOBAL
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SWITZERLAND
9.3.6 NETHERLANDS
9.3.7 RUSSIA
9.3.8 TURKEY
9.3.9 SPAIN
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 THAILAND
9.4.7 MALAYSIA
9.4.8 SINGAPORE
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA
10 GLOBAL WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 COMPANY PROFILE
11.1 MIMEDX.
11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS:
11.1.3 COMPANY SHARE ANALYSIS:
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENTS
11.2 ORGANOGENESIS INC
11.2.1 COMPANY OVERVIEW
11.2.2 GEOGRAPHIC PRESENCE
11.2.3 COMPANY SHARE ANALYSIS:
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENTS
11.3 INTEGRA LIFESCIENCES
11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS:
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 CONVATEC INC.
11.4.1 COMPANY OVERVIEW
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS:
11.4.4 PRODUCT PORTFOLIO :
11.4.5 RECENT DEVELOPMENTS
11.5 ACELL INC.
11.5.1 COMPANY OVERVIEW
11.5.2 PRODUCT PORTFOLIO
11.5.3 RECENT DEVELOPMENTS
11.6 ALLOSOURCE
11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS
11.7 ALPHATEC SPINE, INC. ( A SUBSIDARY OF ALPHATEC HOLDINGS, INC)
11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 AMNIO TECHNOLOGY, LLC
11.8.1 COMPANY OVERVIEW
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 AMNIOX MEDICAL, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS
11.10 ANIKA THERAPEUTICS, INC.
11.10.1 COMPANY OVERVIEW
11.10.2 REVENUE ANALYSIS
11.10.3 PRODUCT PORTFOLIO
11.10.4 RECENT DEVELOPMENTS
11.11 BIOHORIZONS IPH, INC ( A SUBSIDARY OF HENRY SCHEIN, INC.)
11.11.1 COMPANY OVERVIEW
11.11.2 GEOGRAPHICPRESENCE
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS
11.12 KERECIS
11.12.1 COMPANY OVERVIEW
11.12.2 GEOGRAPHICAL PRESENCE
11.12.3 PRODUCT PORTFOLIO
11.12.4 RECENT DEVELOPMENTS
11.13 MARINE POLYMER TECHNOLOGIES, INC
11.13.1 COMPANY OVERVIEW
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 MÖLNLYCKE HEALTH CARE AB
11.14.1 COMPANY OVERVIEW
11.14.2 REVENUE ANALYSIS
11.14.3 PRODUCT PORTFOLIO
11.14.4 RECENT DEVELOPMENTS
11.15 OSIRIS THERAPEUTICS, INC.
11.15.1 COMPANY OVERVIEW
11.15.2 REVENUE ANALYSIS
11.15.3 PRODUCT PORTFOLIO
11.15.4 RECENT DEVELOPMENTS
11.16 SKYE BIOLOGICS INC.
11.16.1 COMPANY OVERVIEW
11.16.2 PRODUCT PORTFOLIO :
11.16.3 RECENT DEVELOPMENT:
11.17 SMITH AND NEPHEW
11.17.1 COMPANY OVERVIEW
11.17.2 REVENUE ANALYSIS
11.17.3 PRODUCT PORTFOLIO
11.17.4 RECENT DEVELOPMENTS
11.18 SOLSYS MEDICAL.
11.18.1 COMPANY OVERVIEW
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENTS
11.19 VERICEL CORPORATION.
11.19.1 COMPANY OVERVIEW
11.19.2 1.1.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.20 WRIGHT MEDICAL GROUP N.V
11.20.1 COMPANY OVERVIEW
11.20.2 1.1.2 REVENUE ANALYSIS
11.20.3 PRODUCT PORTFOLIO
11.20.4 RECENT DEVELOPMENTS
12 RELATED REPORTS
Tabellenverzeichnis
LIST OF TABLES GLOBAL WOUND CARE BIOLOGICS MARKET
TABLE 1 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 2 GLOBAL SYNTHETIC SKIN GRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 3 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 4 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 5 GLOBAL ALLOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 6 GLOBAL XENOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2015– 2025 (USD MILLION)
TABLE 8 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 9 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016– 2025 (USD MILLION)
TABLE 10 GLOBAL SURGICAL WOUND IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 11 GLOBAL SKIN SURGERY IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 12 NUMBER OF COSMETIC SURGERY, 2016 & 2017
TABLE 13 GLOBAL COSMETIC SURGERY IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 14 GLOBAL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 15 GLOBAL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2018-2025 (USD MILLION)
TABLE 16 GLOBAL BURNS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 17 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 18 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2016-2025 (USD MILLION)
TABLE 19 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, 2016 – 2025 (USD MILLION)
TABLE 20 GLOBAL HOSPITALS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 21 GLOBAL WOUND CARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 22 STATISTICS FOR AMBULATORY SURGICAL CENTER. U.S.
TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 24 GLOBAL CLINICS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 25 GLOBAL COMMUNITY HEALTHCARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 26 GLOBAL WOUND CARE BIOLOGICS MARKET, BY GEOGRAPHY, USD MILLION (2016-2025)
TABLE 27 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION )
TABLE 28 NORTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 29 NORTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 30 NORTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 31 NORTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 32 NORTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 33 NORTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 34 NORTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 35 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 36 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 37 NORTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 38 NORTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 39 U.S. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 40 U.S. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 41 U.S. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 42 U.S. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 43 U.S. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 44 U.S. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 45 U.S. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 46 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 47 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 48 U.S. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 49 U.S. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 50 CANADA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 51 CANADA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 52 CANADA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 53 CANADA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 54 CANADA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 55 CANADA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 56 CANADA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 57 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 58 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 59 CANADA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 60 CANADA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 61 MEXICO WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 62 MEXICO GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 63 MEXICO WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 64 MEXICO WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 65 MEXICO SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 66 MEXICO SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 67 MEXICO COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 68 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 69 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 70 MEXICO ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 71 MEXICO WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 72 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 73 EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 74 EUROPE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 75 EUROPE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 76 EUROPE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 77 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 78 EUROPE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 79 EUROPE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 80 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 81 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 82 EUROPE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 83 EUROPE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 84 GERMANY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 85 GERMANY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 86 GERMANY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 87 GERMANY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 88 GERMANY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 89 GERMANY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 90 GERMANY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 91 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 92 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 93 GERMANY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 94 GERMANY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 95 FRANCE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 96 FRANCE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 97 FRANCE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 98 FRANCE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 99 FRANCE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 100 FRANCE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 101 FRANCE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 102 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 103 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 104 FRANCE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 105 FRANCE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 106 U.K. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 107 U.K. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 108 U.K. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 109 U.K. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 110 U.K. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 111 U.K. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 112 U.K. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 113 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 114 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 115 U.K. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 116 U.K. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 117 ITALY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 118 ITALY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 119 ITALY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 120 ITALY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 121 ITALY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 122 ITALY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 123 ITALY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 124 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 125 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 126 ITALY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 127 ITALY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 128 SWITZERLAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 129 SWITZERLAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 130 SWITZERLAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 131 SWITZERLAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 132 SWITZERLAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 133 SWITZERLAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 134 SWITZERLAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 135 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 136 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 137 SWITZERLAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 138 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 139 NETHERLANDS WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 140 NETHERLANDS GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 141 NETHERLANDS WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 142 NETHERLANDS WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 143 NETHERLANDS SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 144 NETHERLANDS SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 145 NETHERLANDS COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 146 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 147 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 148 NETHERLANDS ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 149 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 150 RUSSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 151 RUSSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 152 RUSSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 153 RUSSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 154 RUSSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 155 RUSSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 156 RUSSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 157 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 158 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 159 RUSSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 160 RUSSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 161 TURKEY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 162 TURKEY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 163 TURKEY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 164 TURKEY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 165 TURKEY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 166 TURKEY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 167 TURKEY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 168 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 169 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 170 TURKEY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 171 TURKEY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 172 SPAIN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 173 SPAIN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 174 SPAIN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 175 SPAIN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 176 SPAIN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 177 SPAIN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 178 SPAIN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 179 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 180 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 181 SPAIN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 182 SPAIN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 183 BELGIUM WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 184 BELGIUM GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 185 BELGIUM WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 186 BELGIUM WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 187 BELGIUM SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 188 BELGIUM SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 189 BELGIUM COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 190 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 191 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 192 BELGIUM ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 193 BELGIUM WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 194 REST OF EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 195 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)
TABLE 196 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 197 ASIA-PACIFIC GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 198 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 199 ASIA-PACIFIC WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 200 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 201 ASIA-PACIFIC SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 202 ASIA-PACIFIC COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 203 ASIA-PACIFIC GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 204 ASIA-PACIFIC GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 205 ASIA-PACIFIC ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 206 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 207 CHINA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 208 CHINA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 209 CHINA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 210 CHINA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 211 CHINA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 212 CHINA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 213 CHINA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 214 CHINA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 215 CHINA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 216 CHINA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 217 CHINA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 218 JAPAN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 219 JAPAN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 220 JAPAN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 221 JAPAN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 222 JAPAN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 223 JAPAN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 224 JAPAN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 225 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 226 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 227 JAPAN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 228 JAPAN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 229 INDIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 230 INDIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 231 INDIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 232 INDIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 233 INDIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 234 INDIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 235 INDIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 236 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 237 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 238 INDIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 239 INDIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 240 SOUTH KOREA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 241 SOUTH KOREA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 242 SOUTH KOREA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 243 SOUTH KOREA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 244 SOUTH KOREA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 245 SOUTH KOREA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 246 SOUTH KOREA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 247 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 248 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 249 SOUTH KOREA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 250 SOUTH KOREA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 251 AUSTRALIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 252 AUSTRALIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 253 AUSTRALIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 254 AUSTRALIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 255 AUSTRALIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 256 AUSTRALIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 257 AUSTRALIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 258 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 259 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 260 AUSTRALIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 261 AUSTRALIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 262 THAILAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 263 THAILAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 264 THAILAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 265 THAILAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 266 THAILAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 267 THAILAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 268 THAILAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 269 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 270 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 271 THAILAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 272 THAILAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 273 MALAYSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 274 MALAYSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 275 MALAYSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 276 MALAYSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 277 MALAYSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 278 MALAYSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 279 MALAYSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 280 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 281 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 282 MALAYSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 283 MALAYSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 284 SINGAPORE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 285 SINGAPORE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 286 SINGAPORE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 287 SINGAPORE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 288 SINGAPORE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 289 SINGAPORE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 290 SINGAPORE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 291 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 292 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 293 SINGAPORE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 294 SINGAPORE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 295 INDONESIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 296 INDONESIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 297 INDONESIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 298 INDONESIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 299 INDONESIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, “2016-2025, (USD MILLION)
TABLE 300 INDONESIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 301 INDONESIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 302 INDONESIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 303 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 304 INDONESIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 305 INDONESIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 306 PHILIPPINES WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 307 PHILIPPINES GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 308 PHILIPPINES WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 309 PHILIPPINES WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 310 PHILIPPINES SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 311 PHILIPPINES SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 312 PHILIPPINES COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 313 PHILIPPINES GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 314 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 315 PHILIPPINES ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 316 PHILIPPINESWOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 317 REST OF ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 318 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 319 SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 320 SOUTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 321 SOUTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 322 SOUTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 323 SOUTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 324 SOUTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 325 SOUTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 326 SOUTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 327 SOUTH AMERICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 328 SOUTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 329 SOUTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 330 BRAZIL WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 331 BRAZIL GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 332 BRAZIL WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 333 BRAZIL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 334 BRAZIL SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 335 BRAZIL SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 336 BRAZIL COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 337 BRAZIL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 338 BRAZIL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 339 BRAZIL ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 340 BRAZIL WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 341 REST OF SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 342 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 343 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 344 MIDDLE EAST & AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 345 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 346 MIDDLE EAST & AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 347 MIDDLE EAST & AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 350 MIDDLE EAST & AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 351 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 352 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 353 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 354 SOUTH AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 355 SOUTH AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 356 SOUTH AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 357 SOUTH AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 358 SOUTH AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 359 SOUTH AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 360 SOUTH AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 361 SOUTH AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 362 SOUTH AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 363 SOUTH AFRICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 364 SOUTH AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 365 REST OF MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Abbildungsverzeichnis
LIST OF FIGURES GLOBAL WOUND CARE BIOLOGICS MARKET
FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL WOUND CARE BIOLOGICS MARKET: RESEARCH SNAPSHOT
FIGURE 4 GLOBAL WOUND CARE BIOLOGICS MARKET: BOTTOM UP APPROACH
FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: TOP DOWN APPROACH
FIGURE 6 GLOBAL WOUND CARE BIOLOGICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: DBMR MARKET POSITION GRID
FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL WOUND CARE BIOLOGICS MARKET
FIGURE 4 AGING POPULATION IN DIFFERENT COUNTRIES (2014, 2017 & 2020)
FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 6 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL WOUND CARE BIOLOGICS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
FIGURE 7 INCREASING PREVELANCE OF DIABETIC FOOT ULCERS AND INCREASING INCIDENCES OF BURN CASES ARE EXPECTED TO DRIVE THE MARKET FOR GLOBAL WOUND CARE BIOLOGICS IN THE FORECAST PERIOD 2018 TO 2025
FIGURE 8 SYNTHETIC SKIN GRAFTS IN GLOBAL WOUND CARE BIOLOGICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL WOUND CARE BIOLOGICS MARKET IN 2018 & 2025
FIGURE 9 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL WOUND CARE BIOLOGICS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62
FIGURE 10 WORLDWIDE PREVALENCE OF VARIOUS WOUND TYPES, 2011
FIGURE 11 CASES OF BURN INJURIES, (2009 – 2012)
FIGURE 12 PREVALENCE OF PRESSURE ULCERS IN FEW COUNTRIES
FIGURE 13 NUMBER OF SURGICAL PROCEDURES AND SURGICAL SITE INFECTIONS
FIGURE 14 GLOBAL WOUND CARE BIOLOGICS MARKET: BY PRODUCT TYPE, 2017
FIGURE 15 GLOBAL WOUND CARE BIOLOGICS MARKET: BY WOUND TYPE, 2017
FIGURE 16 GLOBAL WOUND CARE BIOLOGICS MARKET: BY END USER, SNAPSHOT 2017
FIGURE 17 GLOBAL WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 18 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 19 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 20 GLOBAL WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 21 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 22 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 23 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 24 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 25 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 26 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 27 EUROPE WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 28 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 29 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 30 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 31 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 32 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 33 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 34 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 35 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 36 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 37 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 38 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 39 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 40 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 41 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 42 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 43 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 44 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 45 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 46 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 47 GLOBAL WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 48 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 49 EUROPE WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 50 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
